- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 207/34
Total number of patents in this class: 560
10-year publication summary
|
29
|
26
|
30
|
37
|
46
|
30
|
34
|
21
|
22
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1891 |
17 |
| Sunshine Lake Pharma Co., Ltd. | 618 |
17 |
| Takeda Pharmaceutical Company Limited | 2717 |
16 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 749 |
12 |
| Viatris Specialty LLC | 161 |
11 |
| Syngenta Crop Protection AG | 6570 |
9 |
| Theravance Biopharma R&D IP, LLC | 417 |
8 |
| Activesite Pharmaceuticals, Inc. | 18 |
7 |
| FUJIFILM Corporation | 30313 |
6 |
| Global Blood Therapeutics, Inc. | 176 |
6 |
| New York Blood Center, Inc. | 169 |
6 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
6 |
| Novartis AG | 10340 |
5 |
| AstraZeneca AB | 2823 |
5 |
| Syngenta Participations AG | 1575 |
5 |
| Bayer Cropscience AG | 1879 |
5 |
| Astellas Pharma Inc. | 1036 |
5 |
| Emory University | 1705 |
5 |
| Ono Pharmaceutical Co., Ltd. | 419 |
5 |
| University of Maryland, Baltimore | 1055 |
5 |
| Other owners | 399 |